Hong Kong Showcases Organ Transplant Innovations at Nanjing Hepatobiliary Surgery Symposium

Secretary for Health attends 13th Nanjing Academic Symposium on Hepatobiliary Surgery and Liver Transplantation in Nanjing

The Secretary for Health, Professor LoChung-mau,attended the 13th Nanjing Academic Symposium on Hepatobiliary Surgery and Liver Transplantation in Nanjing today (July 12) to share with liver transplant experts from around the world Hong Kong's latest developments in organ transplantation, and the work of the Hong Kong Special Administrative Region (HKSAR) Government in co-operation with the Mainland on organ donation and transplantation.

In his address at the opening ceremony, Professor Lo said, "Hong Kong and the Mainland have a long-standing collaboration in hepatobiliary surgery. I have personally witnessed experts from both places jointly performing a number of complex liver transplant surgeries, achieving in-depth integration of technology and resources, which is an exemplary model of medical co-operation under the 'one country, two systems' framework. In recent years, Hong Kong and the Mainland have also made breakthroughs in organ donation and transplantation. In December 2022 and February this year, two cases of cross-boundary heart donation successfully saved the lives of two infants, exemplifying to the fullest the inseparable ties between the Mainland and Hong Kong as well as our shared principle and mission in protecting and saving lives. With the accumulation of experience, the channels and procedures for handling urgent cross-boundary organ transplant requests have now been streamlined and standardised. The HKSAR Government will continue to explore arrangements for regularising this mechanism."

He also shared the latest developments in the prevention and control of liver disease in Hong Kong. He said, "Since 1988, Hong Kong has provided universal hepatitis B vaccination for all newborns, significantly reducing infection rates among younger generations. As outlined in last year's Policy Address, the Chief Executive also proposed to implement hepatitis B screening to prevent liver cancer. If patients can be identified at an early stage, it will facilitate 'early identification and early treatment', thereby effectively reducing risks of developing complications including cirrhosis and liver cancer."

The conference was jointly organised by the Jiangsu Anti-cancer Association, the Jiangsu Medical Doctor Association, and the Jiangsu Medical Association. The conference brought together international experts and scholars in liver disease, as well as senior health officials from around the world.

Professor Lo then visited the Jiangsu Province Hospital (the First Affiliated Hospital with Nanjing Medical University), where he exchanged views and shared experiences on enhancing hospital management and services with the President of Jiangsu Province Hospital (the First Affiliated Hospital with Nanjing Medical University), Professor Liu Yun. He said, "The Hospital Authority (HA) is adopting China's International Hospital Accreditation Standards (2021 Version) developed by the Shenzhen Hospital Accreditation Research Centre to resume the hospital accreditation programme at its public hospitals. Through independent professional hospital accreditation organisations, various aspects of hospital performance are assessed in an objective manner, with a view to enhancing the quality of healthcare institutions and safeguarding patient safety. Moreover, the HA seeks to optimise the diagnosis process of the relevant specialties and improve the treatment outcomes through the establishment of the first stroke centre at Tuen Mun Hospital, as well as chest pain centres at both Queen Mary Hospital and Prince of Wales Hospital in accordance with national accreditation standards, thereby enhancing the survival rate of patients."

Professor Lo added, "The HKSAR Government will continue to promote the accreditation programme under the Standards as well as the establishment of chest pain centres and stroke centres. These initiatives will not only improve healthcare integration within the Guangdong-Hong Kong-Macao Greater Bay Area and support Hong Kong's integration into national development, but also leverage Hong Kong's advantages of enjoying strong support of the motherland and being closely connected to the world, so as to demonstrate the excellence of the national hospital accreditation standards to the international community."

The Assistant Director of Health (Drug), Mr Frank Chan; the Director (Quality and Safety) of the HA, Dr Michael Wong, and the Cluster Chief Executive of Hong Kong West Cluster of the HA, Dr Theresa Li, accompanied Professor Lo to attend today's functions. They will return to Hong Kong this afternoon.

Secretary for Health attends 13th Nanjing Academic Symposium on Hepatobiliary Surgery and Liver Transplantation in Nanjing Source: HKSAR Government Press Releases

Secretary for Health attends 13th Nanjing Academic Symposium on Hepatobiliary Surgery and Liver Transplantation in Nanjing Source: HKSAR Government Press Releases

Secretary for Health attends 13th Nanjing Academic Symposium on Hepatobiliary Surgery and Liver Transplantation in Nanjing Source: HKSAR Government Press Releases

Secretary for Health attends 13th Nanjing Academic Symposium on Hepatobiliary Surgery and Liver Transplantation in Nanjing Source: HKSAR Government Press Releases

Secretary for Health attends 13th Nanjing Academic Symposium on Hepatobiliary Surgery and Liver Transplantation in Nanjing Source: HKSAR Government Press Releases

Companies Registry releases statistics for 2025

According to the statistics released by the Companies Registry today (January 16), a total of 195,343 local companies and re-domiciled companies were newly registered in 2025. By the end of 2025, the total number of local companies and re-domiciled companies registered under the Companies Ordinance increased by 96,609 compared to 2024, reaching 1,557,103, which was an all-time high figure.

In 2025, 1,532 non-Hong Kong companies that had newly established a place of business in Hong Kong were registered under the Companies Ordinance. By the end of 2025, the total number of registered non-Hong Kong companies was 15,586, up 3 per cent compared to 2024.

The company re-domiciliation regime, implemented since May 23, 2025, has received a positive market response. By the end of 2025, the Registry had received over 420 enquiries and 30 applications. Among these, six non-Hong Kong corporations incorporated in Luxembourg, the Cayman Islands or Bermuda, including an insurance company, have been successfully re-domiciled to Hong Kong. The regime provides a simple and cost-effective pathway for non-Hong Kong incorporated companies to re-domicile to Hong Kong by eliminating the need for complicated and costly judicial procedures while preserving a company's legal identity. It ensures seamless business continuity and strengthens the competitiveness of Hong Kong as a global business and financial hub.

In 2025, the number of charges on properties of companies received for registration was 12,912, which was 6.4 per cent up from 12,137 in 2024. The number of notifications of payments and releases received for registration increased by 14.2 per cent, from 18,201 in 2024 to 20,789 in 2025.

In 2025, a total of 180 prospectuses were registered while the figure recorded in 2024 was 157.

In 2025, the total number of documents delivered for registration increased by 7 per cent to 3,360,723, compared to 3,139,906 in 2024.

In 2025, a total of 5,229,202 searches of document image records were conducted using the Registry's electronic search services, an increase of 0.7 per cent from 5,194,865 in 2024.

On the registration of limited partnership funds (LPFs), a total of 389 LPFs were newly registered in 2025. By the end of 2025, the total number of LPFs increased by 35.1 per cent compared to the end of 2024, to 1,347.

For open-ended fund companies (OFCs), 210 OFCs were newly incorporated in 2025. By the end of 2025, the total number of OFCs increased by 43.2 per cent compared to the end of 2024, to 676.

As regards the licensing of trust or company service providers under the Anti-Money Laundering and Counter-Terrorist Financing Ordinance, a total of 760 new licences were granted by the Registry in 2025. By the end of 2025, the total number of licensees was 7,220.

Turning to the licensing of money lenders, 155 new licences were granted by the Licensing Court in 2025. By the end of 2025, the total number of licensed money lenders was 2,015.

For details of the statistics, please visit the "Statistics" section of the Registry's website (www.cr.gov.hk).

Source: AI-found images